Table 3.

Log hormone levels and DM/HOMA-IR in HIV-infected and HIV-uninfected participants^*

	Outcome: DM			Outcome: HOMA-IR
	FT Model OR (95% CI)	SHBG Model OR (95% CI)	SHBG Model** OR (95% CI)	FT Model β (p)	SHBG Model β (p)
Log hormone‡	0.77 (0.44, 1.36)	0.44 (0.25, 0.80)	0.39 (0.21, 0.74)	−0.11 (0.04)	−0.14 (<0.01)
HIV-infected/HIV-uninfected	1.98 (1.04, 3.78)	2.30 (1.20, 4.38)	2.16 (1.08, 4.31)	0.21 (<0.0001)	0.24 (<0.0001)

Table 3a. AM blood draws only (N=532)
	Outcome: DM			Outcome: HOMA-IR
	FT Model OR (95% CI)	SHBG Model OR (95% CI)	SHBG Model** OR (95% CI)	FT Model β (p)	SHBG Model β (p)
Log hormone‡	0.46 (0.22, 1.00)	0.71 (0.34, 1.48)	0.64 (0.30, 1.38)	−0.17 (0.02)	−0.11 (0.10)
HIV-infected/HIV-uninfected	2.00 (0.84, 4.76)	2.19 (0.93, 5.16)	2.32 (0.89, 5.60)	0.19 (0.01)	0.21 (0.002)

^*All models adjusted for log hormone, HIV, age, center, black race, BMI, HCV status, and waist circumference

^**Adjusted for insulin

^‡Odds ratio corresponds to each 1-log increase in either FT or SHBG.